Safety and Immunogenicity of a Cell Culture-derived Influenza Vaccine in Healthy Adults and Elderly
Clinical trial NCT00492063 · COMPLETED
Trial details
- NCT number
- NCT00492063
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2004-12-01
- Enrollment
- 2654
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.